Rivaroxaban 2.5 mg BID and Aspirin for Intermittent Claudication in PAD Patients
Clinical trial NCT04853719 · COMPLETED
Trial details
- NCT number
- NCT04853719
- Sponsor
- Science Valley Research Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-20
- Primary completion
- 2022-11-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.